ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 52 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,457,519 | -11.8% | 1,074,101 | +2.2% | 0.81% | -18.0% |
| Q2 2023 | $5,056,594 | +18.5% | 1,051,267 | 0.0% | 0.99% | +18.1% |
| Q1 2023 | $4,268,144 | -29.2% | 1,051,267 | -5.8% | 0.84% | -29.1% |
| Q4 2022 | $6,029,537 | -49.9% | 1,116,581 | -7.0% | 1.18% | -59.2% |
| Q3 2022 | $12,036,000 | +69.0% | 1,200,000 | -20.8% | 2.90% | +69.7% |
| Q2 2022 | $7,121,000 | +96.2% | 1,515,000 | +63.2% | 1.71% | +94.8% |
| Q1 2022 | $3,630,000 | – | 928,282 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $13,361,000 | 2.79% |
| GREAT POINT PARTNERS LLC | 928,282 | $3,630,000 | 0.88% |
| RA Capital Management | 9,770,773 | $38,204,000 | 0.83% |
| GUARDIAN POINT CAPITAL, LP | 500,000 | $1,955,000 | 0.71% |
| Deep Track Capital, LP | 2,599,098 | $10,162,000 | 0.65% |
| WMS Partners, LLC | 181,068 | $708,000 | 0.10% |
| Perceptive Advisors | 596,942 | $2,334,000 | 0.05% |
| BVF INC/IL | 289,663 | $1,133,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 358,482 | $1,402,000 | 0.04% |
| Woodline Partners LP | 501,236 | $1,960,000 | 0.03% |